Benign prostatic hyperplasia, or BPH, affects approximately 50% of men between ages 51 and 60, and up to 90% of men over age 80. Despite its staggering prevalence, BPH remains widely misunderstood. The term “benign” is crucial—BPH is not cancer and does not increase cancer risk. Instead, it describes an age-related, non-cancerous enlargement of the prostate gland. As the prostate grows, it squeezes the urethra, the tube that carries urine from the bladder out of the body. This physical compression creates a cascade of frustrating urinary symptoms: hesitancy (difficulty starting urine flow), a weak or intermittent stream, dribbling at the end of urination, and the constant feeling that the bladder is never fully empty. For many men, these symptoms gradually erode quality of life, disrupting sleep with frequent nighttime trips to the bathroom and causing anxiety during travel or long meetings.

The root cause of BPH lies in hormonal shifts that accompany aging. Testosterone is converted into dihydrotestosterone (DHT) by an enzyme called 5-alpha-reductase. DHT is a more potent androgen that directly stimulates prostate cell growth. Over decades, this chronic stimulation leads to the gradual enlargement of the gland’s transition zone—the area surrounding the urethra. Lifestyle factors also play a significant role. Obesity, particularly excess abdominal fat, increases inflammation and estrogen levels, both of which exacerbate BPH symptoms. Conversely, regular physical activity, even brisk walking for 30 minutes daily, has been shown to reduce symptom severity by improving circulation and reducing systemic inflammation. Dietary choices matter too: high consumption of red meat and processed foods correlates with worse symptoms, while a plant-rich diet with lycopene from cooked tomatoes appears protective.

Treatment for BPH has evolved dramatically. For mild cases, watchful waiting combined with lifestyle modifications—reducing evening fluid intake, avoiding decongestants, and double-voiding (urinating twice within a few minutes)—may suffice. For moderate symptoms, alpha-blockers like tamsulosin relax prostate smooth muscle, while 5-alpha-reductase inhibitors like finasteride actually shrink the gland over months. When medications fail or side effects are intolerable, minimally invasive procedures offer relief. Rezum uses steam to destroy excess prostate tissue; UroLift lifts and holds the enlarged lobes apart like curtain ties; and GreenLight laser therapy vaporizes tissue with precision. These procedures are performed on an outpatient basis, preserve sexual function better than older surgeries, and allow men to return to normal activities within days, reclaiming their sleep and confidence.